Jane Street’s Oncorus, Inc. ONCR Stock Holding History

Jane Street’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,972	Closed	-$3.03K	–	10350
2022 Q4	$3.03K	Buy	+11,972	New	+$6.81K	﹤0.01%	8909

Other funds holding ONCR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's ONCR Position: Q1 2023 in Review

Jane Street sold out of Oncorus, Inc. (ONCR) in Q1 2023, closing a stake of 11,972 shares — an estimated $3.03K sold.

Jane Street first reported a position in ONCR in Q4 2022 and held it in 1 quarter. The position peaked at $3.03K in Q4 2022. 32 funds tracked by Wall St. Rank hold ONCR as of Q1 2023.

Jane Street reported no remaining Oncorus, Inc. position as of Q1 2023 after selling out during the quarter.
Jane Street sold 11,972 Oncorus, Inc. shares in Q1 2023, an estimated $3.03K.
Jane Street first reported a position in Oncorus, Inc. in Q4 2022 and held it in 1 quarter.
Jane Street's Oncorus, Inc. position peaked at $3.03K in Q4 2022.
32 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.